These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4835131)

  • 41. Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses.
    Liuzzi A; Chiodini PG; Botalla L; Silvestrini F; Müller EE
    J Clin Endocrinol Metab; 1974 Nov; 39(5):871-6. PubMed ID: 4214404
    [No Abstract]   [Full Text] [Related]  

  • 42. Levodopa suppression of prolactin in nonpuerperal galactorrhea.
    Malarkey WB; Jacobs LS; Daughaday WH
    N Engl J Med; 1971 Nov; 285(21):1160-3. PubMed ID: 5107027
    [No Abstract]   [Full Text] [Related]  

  • 43. Induction of pseudopregnancy in the rat with no rise in serum prolactin.
    Wuttke W; Meites J
    Endocrinology; 1972 Feb; 90(2):438-43. PubMed ID: 5061854
    [No Abstract]   [Full Text] [Related]  

  • 44. The pathophysiology of hyperprolactinemic states and the role of newer ergot compounds in their treatment.
    Frantz AG; Kleinberg DL
    Fed Proc; 1978 Jun; 37(8):2192-7. PubMed ID: 26606
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum.
    Lal S; De la Vega CE; Sourkes TL; Friesen HG
    J Clin Endocrinol Metab; 1973 Nov; 37(5):719-24. PubMed ID: 4749446
    [No Abstract]   [Full Text] [Related]  

  • 46. The inability of bromocriptine to inhibit prolactin secretion by transplantable rat pituitary tumors: observations on the mechanism and dynamics of the autofeedback regulation of prolactin secretion.
    Lamberts SW; MacLeod RM
    Endocrinology; 1979 Jan; 104(1):65-70. PubMed ID: 446356
    [No Abstract]   [Full Text] [Related]  

  • 47. The role of prolactin in the luteotrophic process of lactating rats.
    Ford JJ; Yoshinaga K
    Endocrinology; 1975 Feb; 96(2):335-9. PubMed ID: 163183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional evaluation of prolactin secretion: a guide to therapy.
    Friesen H; Guyda H; Hwang P; Tyson JE; Barbeau A
    J Clin Invest; 1972 Mar; 51(3):706-9. PubMed ID: 4622109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Turning behaviour elicited by apomorphine, (+)-amphetamine and three ergot derivatives in rats treated with a unilateral injection of ethanolamine-O-sulphate in the substantia nigra [proceedings].
    Jaton AL; Loew DM; Vigouret JM
    Br J Pharmacol; 1977 Mar; 59(3):464P-465P. PubMed ID: 843708
    [No Abstract]   [Full Text] [Related]  

  • 50. Serum FSH rise induced by CB-154 (2-Br-alpha-ergocryptine) in postpartum women.
    Seki K; Seki M; Okumura T
    J Clin Endocrinol Metab; 1974 Jul; 39(1):184-6. PubMed ID: 4858181
    [No Abstract]   [Full Text] [Related]  

  • 51. An ergocryptine as a lactation inhibitor.
    Falzon MD; Galea R; Cmailleri AP
    Gynecol Invest; 1974; 5(3):133-8. PubMed ID: 4615051
    [No Abstract]   [Full Text] [Related]  

  • 52. Prolactin and breast carcinoma.
    Smithline F; Sherman L; Kolodny D
    N Engl J Med; 1975 Apr; 292(15):784-92. PubMed ID: 1089886
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interactions in sheep between tall fescue ergot alkaloids and hepatotoxic carbon tetrachloride and Senecio pyrrolizidine alkaloids.
    Debessai WT; Huan J; Cheeke PR
    Vet Hum Toxicol; 1999 Jun; 41(3):129-33. PubMed ID: 10349699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of apomorphine hydrochloride, dibutyryl-apomorphine and Lysenyl on plasma prolactin concentrations in the rat.
    Horowski R; Neumann F; Gräf KJ
    J Pharm Pharmacol; 1975 Jul; 27(7):532-4. PubMed ID: 239161
    [No Abstract]   [Full Text] [Related]  

  • 55. [Studies on the role of endogenous opioid peptides in the regulation of prolactin secretion in the rats (author's transl)].
    Okajima T
    Fukuoka Igaku Zasshi; 1980 Jul; 71(7):400-7. PubMed ID: 7216116
    [No Abstract]   [Full Text] [Related]  

  • 56. Apomorphine does not affect the basal insulin secretion in humans.
    Huupponen R; Pihlajamäki K; Scheinin M
    Horm Metab Res; 1985 Jan; 17(1):41-2. PubMed ID: 3881325
    [No Abstract]   [Full Text] [Related]  

  • 57. Iatrogenic femoral neuropathy.
    Parke L; Horrobin DF
    Br Med J; 1976 Jan; 1(6004):262-3. PubMed ID: 1247810
    [No Abstract]   [Full Text] [Related]  

  • 58. Induction of tolerance of dopaminergic responses in man.
    Lal S; Thavundayil JX; Ng Ying Kin NM; Dai X; Schwartz G; Montoya A
    J Neural Transm (Vienna); 2008 Aug; 115(8):1189-98. PubMed ID: 18506387
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects.
    Delva NJ; Brooks DL; Franklin M; al-Said K; Hawken ER; Merali Z; Lawson JS; Ravindran AV
    J Psychiatry Neurosci; 2002 Nov; 27(6):429-37. PubMed ID: 12491576
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?
    Dépatie L; Lal S
    J Psychiatry Neurosci; 2001 May; 26(3):203-20. PubMed ID: 11394190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.